Title : Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy.

Pub. Date : 2019

PMID : 31795034






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy. THK5351 monoamine oxidase B Homo sapiens
2 However, the interpretation of [18F]THK5351 uptake has been shown to be confounded by high monoamine oxidase B (MAO-B) availability across the brain in AD. THK5351 monoamine oxidase B Homo sapiens
3 However, the interpretation of [18F]THK5351 uptake has been shown to be confounded by high monoamine oxidase B (MAO-B) availability across the brain in AD. THK5351 monoamine oxidase B Homo sapiens
4 CONCLUSIONS: Similar to AD, the interpretation of [18F]THK5351 uptake in PSP is likely confounded by off-target binding to MAO-B binding sites. THK5351 monoamine oxidase B Homo sapiens